Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

CD44 Deficiency in Mice Protects the Heart Against Angiotensin II-Induced Cardiac Fibrosis.

Yang LW, Qin DZ, James E, McKallip RJ, Wang NP, Zhang WW, Zheng RH, Han QH, Zhao ZQ.

Shock. 2018 Feb 21. doi: 10.1097/SHK.0000000000001132. [Epub ahead of print]

PMID:
29470359
2.

Treatment of Hematological Malignancies with Glycyrrhizic Acid.

Hostetler BJ, Uchakina ON, Ban H, McKallip RJ.

Anticancer Res. 2017 Mar;37(3):997-1004.

PMID:
28314257
3.

Inhibition of hyaluronic acid formation sensitizes chronic myelogenous leukemia to treatment with doxorubicin.

Uchakina ON, Ban H, Hostetler BJ, McKallip RJ.

Glycobiology. 2016 Nov;26(11):1171-1179. doi: 10.1093/glycob/cww064. Epub 2016 Jun 3.

PMID:
27261196
4.

Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis.

Bai F, Pang XF, Zhang LH, Wang NP, McKallip RJ, Garner RE, Zhao ZQ.

Life Sci. 2016 May 15;153:141-52. doi: 10.1016/j.lfs.2016.04.013. Epub 2016 Apr 13.

PMID:
27085217
5.

Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats.

Pang XF, Zhang LH, Bai F, Wang NP, Garner RE, McKallip RJ, Zhao ZQ.

Drug Des Devel Ther. 2015 Nov 11;9:6043-54. doi: 10.2147/DDDT.S95333. eCollection 2015.

6.
7.

Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart.

Zhang LH, Pang XF, Bai F, Wang NP, Shah AI, McKallip RJ, Li XW, Wang X, Zhao ZQ.

Cardiovasc Drugs Ther. 2015 Jun;29(3):243-55. doi: 10.1007/s10557-015-6592-7.

PMID:
25994830
8.

Treatment with the hyaluronic Acid synthesis inhibitor 4-methylumbelliferone suppresses LPS-induced lung inflammation.

McKallip RJ, Ban H, Uchakina ON.

Inflammation. 2015;38(3):1250-9. doi: 10.1007/s10753-014-0092-y.

PMID:
25537799
9.

Treatment with the hyaluronic acid synthesis inhibitor 4-methylumbelliferone suppresses SEB-induced lung inflammation.

McKallip RJ, Hagele HF, Uchakina ON.

Toxins (Basel). 2013 Oct 17;5(10):1814-26. doi: 10.3390/toxins5101814.

10.

Targeting hyaluronic acid production for the treatment of leukemia: treatment with 4-methylumbelliferone leads to induction of MAPK-mediated apoptosis in K562 leukemia.

Uchakina ON, Ban H, McKallip RJ.

Leuk Res. 2013 Oct;37(10):1294-301. doi: 10.1016/j.leukres.2013.07.009. Epub 2013 Jul 19.

PMID:
23876826
11.

Development of a novel treatment for leukemia directed at tumor-associated mRNA splicing.

Daines DA, Sun J, Uchakina ON, McKallip RJ.

Leuk Res. 2013 Sep;37(9):1125-31. doi: 10.1016/j.leukres.2013.06.017. Epub 2013 Jul 3.

PMID:
23830513
12.

The role of hyaluronic acid in SEB-induced acute lung inflammation.

Uchakina ON, Castillejo CM, Bridges CC, McKallip RJ.

Clin Immunol. 2013 Jan;146(1):56-69. doi: 10.1016/j.clim.2012.11.002. Epub 2012 Nov 14.

PMID:
23246605
13.

CD44 as a novel target for treatment of staphylococcal enterotoxin B-induced acute inflammatory lung injury.

Sun J, Law GP, Bridges CC, McKallip RJ.

Clin Immunol. 2012 Jul;144(1):41-52. doi: 10.1016/j.clim.2012.05.001. Epub 2012 May 11.

PMID:
22659034
14.

Role of CD44 in lymphokine-activated killer cell-mediated killing of melanoma.

Sun J, Law GP, McKallip RJ.

Cancer Immunol Immunother. 2012 Mar;61(3):323-34. doi: 10.1007/s00262-011-1105-4. Epub 2011 Sep 8.

PMID:
21901391
15.

Plumbagin treatment leads to apoptosis in human K562 leukemia cells through increased ROS and elevated TRAIL receptor expression.

Sun J, McKallip RJ.

Leuk Res. 2011 Oct;35(10):1402-8. doi: 10.1016/j.leukres.2011.06.018. Epub 2011 Jul 8.

16.

Reference moist smokeless tobacco-induced apoptosis in human monocytes/macrophages cell line MM6.

Lombard C, Farthing D, Sun J, Fariss MW, McKallip RJ.

Int Immunopharmacol. 2010 Sep;10(9):1029-40. doi: 10.1016/j.intimp.2010.06.002. Epub 2010 Jun 22.

PMID:
20601189
17.

Plumbagin-induced apoptosis in lymphocytes is mediated through increased reactive oxygen species production, upregulation of Fas, and activation of the caspase cascade.

McKallip RJ, Lombard C, Sun J, Ramakrishnan R.

Toxicol Appl Pharmacol. 2010 Aug 15;247(1):41-52. doi: 10.1016/j.taap.2010.05.013. Epub 2010 May 26.

PMID:
20576514
18.

Role of oxidative stress and MAPK signaling in reference moist smokeless tobacco-induced HOK-16B cell death.

Mitchell C, Joyce AR, Piper JT, McKallip RJ, Fariss MW.

Toxicol Lett. 2010 May 19;195(1):23-30. doi: 10.1016/j.toxlet.2010.02.020. Epub 2010 Mar 3.

PMID:
20206247
19.

Role of CD4(+)CD25(+) T regulatory cells in IL-2-induced vascular leak.

Melencio L, McKallip RJ, Guan H, Ramakrishnan R, Jain R, Nagarkatti PS, Nagarkatti M.

Int Immunol. 2006 Oct;18(10):1461-71. Epub 2006 Aug 16.

PMID:
16914509
20.

Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression.

McKallip RJ, Jia W, Schlomer J, Warren JW, Nagarkatti PS, Nagarkatti M.

Mol Pharmacol. 2006 Sep;70(3):897-908. Epub 2006 Jun 5.

21.

Mouse B cell activation is inhibited by CD44 cross-linking.

Wyant TL, Fisher MT, McKallip RJ, Nagarkatti PS, Nagarkatti M, Conrad DH.

Immunol Invest. 2005;34(4):399-416.

PMID:
16304729
22.
25.

Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver.

Lombard C, McKallip RJ, Hylemon PB, Nagarkatti PS, Nagarkatti M.

Clin Immunol. 2003 Nov;109(2):144-53.

PMID:
14597213
26.

Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease.

Do Y, Rafi-Janajreh AQ, McKallip RJ, Nagarkatti PS, Nagarkatti M.

Int Immunol. 2003 Nov;15(11):1327-40.

PMID:
14565931
27.

Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by interleukin-2-activated cytolytic lymphocytes.

McKallip RJ, Fisher M, Do Y, Szakal AK, Gunthert U, Nagarkatti PS, Nagarkatti M.

J Biol Chem. 2003 Oct 31;278(44):43818-30. Epub 2003 Aug 6.

28.

Regulation of interleukin-2-induced vascular leak syndrome by targeting CD44 using hyaluronic acid and anti-CD44 antibodies.

Mustafa A, McKallip RJ, Fisher M, Duncan R, Nagarkatti PS, Nagarkatti M.

J Immunother. 2002 Nov-Dec;25(6):476-88.

PMID:
12439345
29.

Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens.

McKallip RJ, Do Y, Fisher MT, Robertson JL, Nagarkatti PS, Nagarkatti M.

Int Immunol. 2002 Sep;14(9):1015-26.

PMID:
12202399
30.

Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arrays.

Zeytun A, McKallip RJ, Fisher M, Camacho I, Nagarkatti M, Nagarkatti PS.

Toxicology. 2002 Sep 16;178(3):241-60.

PMID:
12167310
31.

Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo.

McKallip RJ, Lombard C, Martin BR, Nagarkatti M, Nagarkatti PS.

J Pharmacol Exp Ther. 2002 Aug;302(2):451-65.

32.

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.

McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, Nagarkatti PS, Nagarkatti M.

Blood. 2002 Jul 15;100(2):627-34.

33.

Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus.

Okasha SA, Ryu S, Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS.

Toxicology. 2001 May 28;163(1):49-62.

PMID:
11376864
34.

CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death.

Chen D, McKallip RJ, Zeytun A, Do Y, Lombard C, Robertson JL, Mak TW, Nagarkatti PS, Nagarkatti M.

J Immunol. 2001 May 15;166(10):5889-97.

35.
36.

Immunomodulatory properties of AZT.

McKallip RJ, Nagarkatti M, Nagarkatti P.

Ann N Y Acad Sci. 1993 Jun 23;685:464-6. No abstract available.

PMID:
8363254

Supplemental Content

Loading ...
Support Center